Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? |
Title | Official HCP Website | TECVAYLI™ (teclistamab-cqyv) |
Description | Sorry, you need to enable JavaScript to visit this Learn about TECVAYLI™ (teclistamab-cqyv), an injection treatment, on the official HCP website. See full Safety & Prescribing Information, including Boxed |
Keywords | N/A |
WebSite | tecvaylihcp.com |
Host IP | 104.18.6.196 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2023-05-20 00:02:49
tecvaylihcp.com has Semrush global rank of 0. tecvaylihcp.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. tecvaylihcp.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 104.18.6.196. According to SiteAdvisor, tecvaylihcp.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
tecvaylihcp.com. | A | 1798 | IP: tecvaylihcp.com.cdn.cloudflare.net. |
tecvaylihcp.com.cdn.cloudflare.net. 298 | A | IP: 104.18.6.196 | |
tecvaylihcp.com.cdn.cloudflare.net. 298 | A | IP: 104.18.7.196 | |
tecvaylihcp.com. | NS | 1797 | NS Record: tecvaylihcp.com.cdn.cloudflare.net. |
tecvaylihcp.com. | MX | 1797 | MX Record: tecvaylihcp.com.cdn.cloudflare.net. |
tecvaylihcp.com. | TXT | 1797 | TXT Record: tecvaylihcp.com.cdn.cloudflare.net. |
For Healthcare Professionals Patient Website Prescribing Information Important Safety Information Talk With Us Sign Up for Updates TECVAYLI™ REMS For Healthcare Professionals Toggle navigation Home Multiple Myeloma Discover the Science Clinical Study Results Safety Profile Dosing and Administration Support and Resources For Healthcare Professionals Patient Website Prescribing Information Important Safety Information Talk With Us Sign Up for Updates TECVAYLI™ REMS POWER WITHIN REACH 1 For the 61.8% of patients who achieved ORR in MajesTEC-1 61.8 % ORR * (n=68/110 [95% CI, 52.1%-70.9%]) 28.2 % ≥CR † (n=31/110) 29.1 % VGPR (n=32/110) 4.5 % PR (n=5/110) Choose TECVAYLI™, the first bispecific BCMA × CD3 T-cell engager given as an off-the-shelf subcutaneous injection for adult patients with RRMM who have received at least 4 prior lines of therapy, including a PI, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. 1,2 This indication is approved under accelerated approval based |
HTTP/1.1 301 Moved Permanently Date: Tue, 13 Dec 2022 08:54:44 GMT Content-Type: text/html Connection: keep-alive Location: https://tecvaylihcp.com/ X-Cache: Redirect from cloudfront Via: 1.1 82bb120a49c1eed26f2f41e5d4b1a1b2.cloudfront.net (CloudFront) X-Amz-Cf-Pop: BOM78-P1 X-Amz-Cf-Id: C5XwyFiBxaM9gFDHmZj42azZ0sV8HyzQBwNjQ0BDuxeKTed8cK1lOA== X-XSS-Protection: 1 X-Frame-Options: SAMEORIGIN Referrer-Policy: strict-origin-when-cross-origin Content-Security-Policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; X-Content-Type-Options: nosniff Cache-Control: public, max-age=7889400 CF-Cache-Status: MISS Set-Cookie: JJCFGEOCC=de; Max-Age=3600; Path=/; Domain=.tecvaylihcp.com;=nil Server: cloudflare CF-RAY: 778d7a0d6da19b82-FRA HTTP/2 301 date: Tue, 13 Dec 2022 08:54:45 GMT content-length: 0 location: https://www.tecvaylihcp.com/ x-cache: FunctionGeneratedResponse from cloudfront via: 1.1 509ce38da891ecf809ff75b9d96b074a.cloudfront.net (CloudFront) x-amz-cf-pop: BOM78-P1 x-amz-cf-id: GZrpcfDKJGI34odvTY0O0ZlbPPafIbOy4pns_bZeOY7aUlIyyFy4pA== x-xss-protection: 1 x-frame-options: SAMEORIGIN referrer-policy: strict-origin-when-cross-origin content-security-policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; x-content-type-options: nosniff strict-transport-security: max-age=63072000 cache-control: public, max-age=7889400 cf-cache-status: MISS set-cookie: JJCFGEOCC=de; Max-Age=3600; Path=/; Domain=.tecvaylihcp.com;=nil server: cloudflare cf-ray: 778d7a110eeb909d-FRA HTTP/2 200 date: Tue, 13 Dec 2022 08:54:45 GMT content-type: text/html last-modified: Mon, 12 Dec 2022 21:44:27 GMT x-amz-server-side-encryption: AES256 vary: Accept-Encoding x-cache: Miss from cloudfront via: 1.1 a3e3a116dc27da4ca749ff4c346e64c8.cloudfront.net (CloudFront) x-amz-cf-pop: HYD57-P1 x-amz-cf-id: OOsSo-zlPsXiBgSCFSxGDIdAOTWf22oC-SC1q2soLHOJ6Wob1W0Rog== x-xss-protection: 1 x-frame-options: SAMEORIGIN referrer-policy: strict-origin-when-cross-origin content-security-policy: default-src *; script-src * 'unsafe-eval' 'self' 'unsafe-inline' https:; style-src * 'unsafe-inline'; object-src 'self' *.youtube.com youtube.com; img-src * data:; frame-src *; font-src * data:; connect-src *; media-src * blob:; worker-src 'self' blob:; x-content-type-options: nosniff strict-transport-security: max-age=63072000 cache-control: public, max-age=7889400 cf-cache-status: HIT age: 19359 set-cookie: JJCFGEOCC=at; Max-Age=3600; Path=/; Domain=.tecvaylihcp.com;=nil server: cloudflare cf-ray: 778d7a1799109b76-FRA |
Domain Name: TECVAYLIHCP.COM Registry Domain ID: 2678689634_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2022-03-01T21:13:27Z Creation Date: 2022-03-01T21:13:22Z Registry Expiry Date: 2023-03-01T21:13:22Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.JNJ.COM Name Server: NS3.JNJ.COM Name Server: NS5.JNJ.COM DNSSEC: unsigned >>> Last update of whois database: 2022-12-13T08:41:46Z <<< |